871329-62-3

Basic information

• Product Name: (3-FLUORO-5-METHOXYCARBONYL)BENZENEBORONIC ACID
• Synonyms: METHYL 3-BORONO-5-FLUOROBENZOATE;(3-FLUORO-5-METHOXYCARBONYL)BENZENEBORONIC ACID;(3-FLUORO-5-METHOXYCARBONYLPHENYL)BORONIC ACID;3-Fluoro-5-(methoxycarbonyl)benzeneboronicacid95%;3-Fluoro-5-(methoxycarbonyl)benzeneboronicacid96%
• CAS NO: 871329-62-3
• Molecular Formula: C8H8BFO4
• Molecular Weight: 197.96
• Product Categories: blocks;BoronicAcids;Carboxes;FluoroCompounds
• Mol File: 871329-62-3.mol
• Article Data: 1

Chemical Properties

• Melting Point: 138-142
• Boiling Point: 372.5ºC at 760 mmHg
• Flash Point: 179.1ºC
• Appearance: /
• Density: 1.33g/cm3
• Vapor Pressure: 3.3E-06mmHg at 25°C
• Refractive Index: 1.513
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• Water Solubility: Slightly soluble in water.
• CAS DataBase Reference: (3-FLUORO-5-METHOXYCARBONYL)BENZENEBORONIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: (3-FLUORO-5-METHOXYCARBONYL)BENZENEBORONIC ACID(871329-62-3)
• EPA Substance Registry System: (3-FLUORO-5-METHOXYCARBONYL)BENZENEBORONIC ACID(871329-62-3)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 22
• Hazardous Substances Data: 871329-62-3(Hazardous Substances Data)

Usage

Uses

3-Fluoro-5-(methoxycarbonyl)benzeneboronic acid is used as pharmaceutical intermediate.

InChI:InChI=1/C8H8BFO4/c1-14-8(11)5-2-6(9(12)13)4-7(10)3-5/h2-4,12-13H,1H3

Upstream product

• 67-56-1 methanol 
• 871329-84-9 3-(dihydroxyboranyl)-5-fluorobenzoic acid 

Relevant articles and documents

IMIDAZOTHIADIAZOLE AND IMIDAZOPYRIDAZINE DERIVATIVES AS PROTEASE ACTIVATED RECEPTOR 4 (PAR4) INHIBITORS FOR TREATING PLATELET AGGREGATION

The present invention provides imidazothiadiazole compounds of Formula (I); Wherein W,Y, R0, R2, R4, Ra, Rb, X1, X2, X3 and X4 are as defined herein,, or a stereoisomer, tautomer, pharmaceutically acceptable salt, prodrug ester or solvate form thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of platelet aggregation and thus can be used as medicaments for treating or preventing thromboembolic disorders.